A JAK1 selective inhibitor could soon become a standard treatment option for people with atopic dermatitis, according to a new Irish study.
The post Selective inhibitor JAK1 hailed as new ‘effective treatment’ for chronic dermatitis appeared first on Irish Medical Times.